Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant
- PMID: 31549887
- PMCID: PMC8871599
- DOI: 10.1080/13880209.2019.1662458
Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant
Abstract
Context: The co-delivery of adjuvant and antigen has shown to be more effective for targeting the immune response than antigen alone. Therefore, designing an efficient bicistronic system is more assuring for production of both elements in the same tobacco cells as a plant model system. Objective: Comparing the efficient transient co-expression of hepatitis B surface antigen (HBsAg) and mouse granulocyte macrophage colony stimulating factor (mGM-CSF) in tobacco leaves by designing either mono or bicistronic cassettes. Materials and methods: Four expression cassettes containing tobacco etch virus (TEV) leader sequence were constructed with and without above genes in different orders. The cassettes were transferred into tobacco, Nicotiana tabacum L. (Solanaceae), leaves by agroinfiltration technique. The expression levels were compared using ELISA and western blotting and bioactivity of cytokine was assessed by in vitro proliferation of mouse GM-CSF-responsive progenitor cells. Results: Agroinfiltrated leaves contained recombinant HBsAg protein at 20-50 ng/mg and mGM-CSF at 0.2-4 ng/mg in both nonglycosylated and glycosylated forms. The highest expression obtained in HBsAg and mGM-CSF monocistronic co-agroinfiltrated leaves. The expression of mGM-CSF was 1.1 and 0.2 ng/mg in two different orders of bicistronic cassettes. The growth frequency of GM progenitors was approximately 1/187 cells for standard rGM-CSF and 3.2 times less activity for the plant produced. Discussion and conclusions: The recombinant mGM-CSF was produced less in bicistronic cassette than other forms; however, co-presenting of both vaccine candidate and adjuvant is confirmed and could be promising for amelioration of plant expression system as a means for vaccine production.
Keywords: GM-CSF; HBsAg; Vaccine; co-expression; plant-produced.
Conflict of interest statement
The authors report no conflict of interest.
Figures




Similar articles
-
Transient Co-Expression of Bioactive Murine Interferon-Gamma and HBsAg in Tobacco and Lettuce Leaves.Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):232-238. doi: 10.18502/ajmb.v15i4.13493. Avicenna J Med Biotechnol. 2023. PMID: 38078343 Free PMC article.
-
Recombinant mouse granulocyte-macrophage colony-stimulating factor is glycosylated in transgenic tobacco and maintains its biological activity.J Interferon Cytokine Res. 2010 Mar;30(3):135-42. doi: 10.1089/jir.2009.0053. J Interferon Cytokine Res. 2010. PMID: 20038209
-
A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.Blood. 1995 Oct 1;86(7):2732-40. Blood. 1995. PMID: 7670112
-
Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.Cell Mol Immunol. 2016 Nov;13(6):850-861. doi: 10.1038/cmi.2015.64. Epub 2015 Jul 13. Cell Mol Immunol. 2016. PMID: 26166767 Free PMC article.
-
Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant.Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 2:S47-53. doi: 10.1007/BF01973602. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7875153 Review.
Cited by
-
Transient Co-Expression of Bioactive Murine Interferon-Gamma and HBsAg in Tobacco and Lettuce Leaves.Avicenna J Med Biotechnol. 2023 Oct-Dec;15(4):232-238. doi: 10.18502/ajmb.v15i4.13493. Avicenna J Med Biotechnol. 2023. PMID: 38078343 Free PMC article.
References
-
- Chou HY, Lin XZ, Pan WY, Wu PY, Chang CM, Lin TY, Shen HH, Tao MH. 2010. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells. J Immunol. 185(9):5468–5475. - PubMed
-
- Decker WK, Safdar A. 2011. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease. Cytokine Growth Factor Rev. 22(4):177–187. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources